de Gaetano G, Cerletti C, Evangelista V
Department of Vascular Medicine and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy.
Haemostasis. 1999 Sep;29(1):41-9. doi: 10.1159/000022459.
Epidemiological evidence suggests a positive correlation between the number of PMN and the risk of ischemic vascular disease. The observation that activated PMN induce platelet activation my provide some biological plausibility to the role of PMN in thrombogenesis. Between other PMN products, cathepsin G, a protease released during PMN activation, is a potent platelet agonist. However, the antiproteinases present in plasma could virtually abolish its activity. Indeed it was shown that, when PMN were stimulated after interaction with platelets in mixed cell population, P-selectin-mediated platelet-PMN adhesion may result in the formation of a sequestered microenvironment in which cathepsin G activity is protected by antiproteases. P-selectin-mediated adhesion was also shown to facilitate the transcellular metabolism of arachidonic acid, resulting in increased production of both thromboxane B2 and leukotriene C4. PMN adhesion to activated platelets in mixed cell suspensions subjected to high shear rate can be modeled as an adhesion cascade involving a P-selectin-dependent recognition step followed by an adhesion-strengthening interaction mediated by the beta(2)-integrin Mac-1. Moreover, an intermediate tyrosine-kinase-dependent signal regulating beta(2)-integrin adhesiveness is required. Indeeed activated platelets express not only P-selectin but also different beta(2)-integrin ligands including fibrinogen and ICAM-2. Some of the functional responses elicited by P-selectin on PMN could be prevented by specific antibody to the P-selectin glycoprotein ligand-1, indicating that this adhesive receptor is able to transduce an 'outside-in' signal when engaged by the ligand. By using activated platelets, P-selectin-expressing CHO cells and soluble recombinant P-selectin, P-selectin was shown to trigger protein tyrosine phosphorylation in PMN and the tyrosine kinase-dependent function of Mac-1. In conclusion, adherence of activated platelets to PMN may be a key event in the sequence of thrombus formation. The recognition of the essential contribution of PMN beta(2)-integrins in addition to P-selectin in platelet-PMN adhesion provides an additional evidence to the broad range of function and mechanisms in which PMN integrins are involved and may be potential targets for pharmacological intervention.
流行病学证据表明中性粒细胞数量与缺血性血管疾病风险之间存在正相关。活化的中性粒细胞诱导血小板活化这一观察结果为中性粒细胞在血栓形成中的作用提供了一些生物学合理性。在中性粒细胞的其他产物中,组织蛋白酶G是中性粒细胞活化过程中释放的一种蛋白酶,是一种有效的血小板激动剂。然而,血浆中存在的抗蛋白酶实际上可以消除其活性。事实上,研究表明,当在混合细胞群体中血小板与中性粒细胞相互作用后刺激中性粒细胞时,P-选择素介导的血小板-中性粒细胞黏附可能导致形成一个隔离的微环境,其中组织蛋白酶G的活性受到抗蛋白酶的保护。P-选择素介导的黏附还被证明促进了花生四烯酸的跨细胞代谢,导致血栓素B2和白三烯C4的产生增加。在高剪切速率下,混合细胞悬液中活化血小板与中性粒细胞的黏附可以被模拟为一个黏附级联反应,包括一个P-选择素依赖性识别步骤,随后是由β(2)整合素Mac-1介导的黏附增强相互作用。此外,还需要一个中间的酪氨酸激酶依赖性信号来调节β(2)整合素的黏附性。事实上,活化的血小板不仅表达P-选择素,还表达不同的β(2)整合素配体,包括纤维蛋白原和ICAM-2。P-选择素对中性粒细胞引发的一些功能反应可以被针对P-选择素糖蛋白配体-1的特异性抗体所阻断,这表明这种黏附受体在与配体结合时能够转导一个“由外向内”的信号。通过使用活化血小板、表达P-选择素的CHO细胞和可溶性重组P-选择素,已证明P-选择素可触发中性粒细胞中的蛋白酪氨酸磷酸化以及Mac-1的酪氨酸激酶依赖性功能。总之,活化血小板与中性粒细胞的黏附可能是血栓形成序列中的一个关键事件。除了P-选择素外,认识到中性粒细胞β(2)整合素在血小板-中性粒细胞黏附中的重要贡献,为中性粒细胞整合素所涉及的广泛功能和机制提供了额外证据,并且可能是药物干预的潜在靶点。